TPST
Tempest Therapeutics, Inc.Marquee-fund ownership over time
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Millennium Management | Q1 2025 | Q2 2025 | — | +0% |
| Two Sigma Investments | Q4 2024 | Q1 2025 | — | +0% |
| Citadel Advisors | Q3 2024 | Q4 2024 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Tempest Therapeutics, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 8, 2026 — the most recent Form 4 on file — not from today.
- Form 40001193125-26-262257Jun 8, 2026
- Form 40001947673-26-000002Apr 2, 2026
- Form 40001871423-26-000002Apr 2, 2026
- Form 40001931356-26-000011Mar 25, 2026
- Form 40001931356-26-000006Feb 6, 2026
- Form 40001871563-26-000002Jan 28, 2026
- Form 40001321402-26-000003Jan 28, 2026
- Form 40001214505-26-000003Jan 28, 2026
- Form 40001127430-26-000002Jan 28, 2026
- Form 40001415889-25-000807Jan 6, 2025
- Form 40001415889-25-000806Jan 6, 2025
- Form 40001415889-25-000808Jan 6, 2025
- Form 40001415889-25-000805Jan 6, 2025
- Form 40000950170-24-095675Aug 12, 2024
- Form 40001415889-24-019339Jul 8, 2024
Fundamentals
XBRL · Tempest Therapeutics, Inc.Annual figures sourced directly from Tempest Therapeutics, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Tempest Therapeutics, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- DEF 14AProxy statementJun 8, 2026
- 8-KMaterial eventJun 4, 2026
- 8-KMaterial eventJun 2, 2026
- 8-KMaterial eventMay 29, 2026
- 8-KMaterial eventMay 22, 2026
- 8-KMaterial eventMay 22, 2026
- 10-QQuarterly reportMay 14, 2026
- 8-KMaterial eventMay 14, 2026
- 8-KMaterial eventMay 6, 2026
- S-3Registration (shelf)Apr 2, 2026
- S-3Registration (shelf)Mar 30, 2026
- 10-KAnnual reportMar 30, 2026
- 8-KMaterial eventMar 30, 2026
- 8-KMaterial eventMar 23, 2026
- 8-KMaterial eventFeb 25, 2026
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Millennium Management | Q1 2025 | Q2 2025 | $0.00 | — | +0% |
| Two Sigma Investments | Q4 2024 | Q1 2025 | $0.00 | — | +0% |
| Citadel Advisors | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.